Head-To-Head Review: Vsee Health (NASDAQ:VSEE) versus GeneDx (NASDAQ:WGS)

Vsee Health (NASDAQ:VSEE) and GeneDx (NASDAQ:WGS) are both computer and technology companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, profitability, earnings, institutional ownership, risk and analyst recommendations.

Analyst Ratings

This is a summary of current ratings and target prices for Vsee Health and GeneDx, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Vsee Health	0	0	0	0	0.00
GeneDx	0	3	3	0	2.50

GeneDx has a consensus price target of $72.33, indicating a potential downside of 24.52%. Given GeneDx’s stronger consensus rating and higher probable upside, analysts plainly believe GeneDx is more favorable than Vsee Health.

Valuation and Earnings

This table compares Vsee Health and GeneDx”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Vsee Health	N/A	N/A	-$4.41 million	N/A	N/A
GeneDx	$305.45 million	8.62	-$175.77 million	($1.96)	-48.89

Vsee Health has higher earnings, but lower revenue than GeneDx.

Institutional & Insider Ownership

1.0% of Vsee Health shares are owned by institutional investors. Comparatively, 61.7% of GeneDx shares are owned by institutional investors. 6.6% of Vsee Health shares are owned by insiders. Comparatively, 27.3% of GeneDx shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Profitability

This table compares Vsee Health and GeneDx’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Vsee Health	N/A	-182.59%	-58.26%
GeneDx	-17.12%	3.33%	1.69%

Summary

GeneDx beats Vsee Health on 8 of the 10 factors compared between the two stocks.

About Vsee Health

VSee Health, Inc. is a no-code or low-code software as a service (SaaS) platform that enables clinicians and enterprises to create their telehealth workflows without programming. It engages in providing timely, quality healthcare to patients regardless of geographical barriers. The company is headquartered in Boca Raton, FL.

About GeneDx

GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. was founded in 2017 and is headquartered in Stamford, Connecticut.